Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Dateline
  • Published:

The End of Monoclonal Patents?

Bio/Technology volume 10, pages 1082–1083 (1992)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Author notes

  1. Kevin J. McGough and Daniel P. Burke are patent attorneys whose respective practices in New Jersey and New York involve pharmaceutical and health-care matters.

    Authors
    1. Kevin J. McGough
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Daniel P. Burke
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    McGough, K., Burke, D. The End of Monoclonal Patents?. Nat Biotechnol 10, 1082–1083 (1992). https://doi.org/10.1038/nbt1092-1082

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1038/nbt1092-1082

    Search

    Advanced search

    Quick links

    Nature Briefing

    Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

    Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing